The label contains complete use information, including cautions and warnings. Always read, follow and understand the label and use directions
Pradalex is indicated for the treatment of SRD associated with Bordetella bronchiseptica, Glaesserella (Haemophilus) parasuis, Pasteurella multocida, Streptococcus suis and Mycoplasma hyopneumoniae in weaned swine intended for slaughter (nursery, growing, and finishing swine, boars intended for slaughter, barrows, gilts intended for slaughter, and sows intended for slaughter). Not for use in swine intended for breeding (boars intended for breeding, replacement gilts and sows intended for breeding) and in nursing piglets.
DOSAGE AND ADMINISTRATION:
Swine: Administer once as an intramuscular injection in the neck at a dosage of 7.5 mg/kg (1.7 mL/100 lb) body weight. Do not inject more than 5 mL per intramuscular injection site.
IMPORTANT SAFETY INFORMATION:
CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for use in humans. Keep out of reach of children. Avoid contact with eyes and skin. Individuals with a history of hypersensitivity to quinolones should avoid this product. Not for use in animals intended for breeding because the effects of Pradalex on swine reproductive performance, pregnancy and lactation have not been determined. Not for use in nursing piglets because safety and effectiveness have not been demonstrated. Quinolones should be used with caution in animals with known or suspected central nervous system (CNS) disorders. Mild to moderate inflammatory changes of the injection site may be seen in swine treated with Pradalex. See package insert for additional safety information.